How long will it take for platelets to rise after taking Eltrombopag/Eltrombopag?

Eltrombopag is an oral thrombopoietin receptor agonist that promotes platelet production by stimulating the maturation and proliferation of bone marrow megakaryocytes. It is widely used in diseases such as chronic immune thrombocytopenia (ITP), aplastic anemia (AA), and hepatitis C-related thrombocytopenia. For patients, how long it will take to see an increase in platelet count after taking the drug is one of the most concerning issues.

Generally, a gradual increase in platelets can be observed within the first few weeks of starting eltrombopag. Some patients will see an increase in their platelet count within one to two weeks, while for other patients it may take three to four weeks, or even longer, to show efficacy. Factors that affect this time difference include: type of underlying disease, severity of illness, bone marrow hematopoietic reserve capacity, whether combined with other medications, and individual metabolic differences. Overseas clinical experience also suggests that for refractory patients who have failed previous multiple lines of treatment, a longer period of drug accumulation may be needed to stimulate sufficient platelet production.

It should be noted that the efficacy of eltrombopag varies on an individual basis, and not all patients will achieve ideal platelet levels in the same time. In some patients, the initial increase is obvious, but if the drug is stopped or the dose is reduced too quickly, the platelet count may drop again. Therefore, during the treatment process, it is necessary to regularly review the blood routine according to the doctor's recommendations, and dynamically adjust the dose according to changes in platelets to avoid increasing the risk of thrombosis due to excessive increase, or unstable efficacy due to insufficient dosage.

In addition, patients should strictly follow the medication method while taking the medication, such as taking it on an empty stomach and avoiding taking it with high-calcium foods at the same time, because calcium will affect the drug absorption efficiency, thereby indirectly affecting the speed and amplitude of platelet rise. For patients with abnormal liver function, the dosage needs to be adjusted under the guidance of a doctor to balance efficacy and safety.

Reference materials:https://go.drugbank.com/drugs/DB06210